Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taiyo Shijo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medicine|December 9, 2022
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case reportShuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, et al.
Cureus|August 1, 2024
Familial Occurrence of a Severe Phenotype of Central Serous Chorioretinopathy in Two BrothersYuta Inada, Yoichi Sakurada, Taiyo Shijo, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular EdemaWataru Kikushima, Taiyo Shijo, Yukiko Furuhata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 3, 2017
Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degenerationTaiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, et al.
Photodiagnosis and Photodynamic Therapy|December 7, 2024
Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edemaWataru Kikushima, Yukiko Furuhata, Taiyo Shijo, et al.
JAMA Ophthalmology|April 16, 2026
Cultured Human Corneal Endothelial Cell Injection for Endothelial Graft Failure After DSAEKRintaro Ogino, Mariko Shirane, Taiyo Shijo, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Ophthalmology Science|June 19, 2026
Aqueous Humor Total Protein Levels Predict 6-Year Graft Survival after Endothelial Keratoplasty in Surgically Treated Glaucoma EyesSayaka Kaneko, Yukari Yagi-Yaguchi, Taiyo Shijo, et al.
Retina (Philadelphia, Pa.)|February 20, 2024
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata RegimenWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medicine|December 9, 2022
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case reportShuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, et al.
Cureus|August 1, 2024
Familial Occurrence of a Severe Phenotype of Central Serous Chorioretinopathy in Two BrothersYuta Inada, Yoichi Sakurada, Taiyo Shijo, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular EdemaWataru Kikushima, Taiyo Shijo, Yukiko Furuhata, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 3, 2017
Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degenerationTaiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, et al.
Photodiagnosis and Photodynamic Therapy|December 7, 2024
Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edemaWataru Kikushima, Yukiko Furuhata, Taiyo Shijo, et al.
JAMA Ophthalmology|April 16, 2026
Cultured Human Corneal Endothelial Cell Injection for Endothelial Graft Failure After DSAEKRintaro Ogino, Mariko Shirane, Taiyo Shijo, et al.
Genes|July 29, 2025
Genetic Factors Associated with Intraocular Inflammation After Brolucizumab Administration in Patients with Exudative Age-Related Macular DegenerationSeigo Yoneyama, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|May 19, 2026
Genetic factors associated with response to as-needed brolucizumab treatment for exudative age-related macular degenerationSeigo Yoneyama, Yoichi Sakurada, Yoshiko Fukuda, et al.
Ophthalmology Science|June 19, 2026
Aqueous Humor Total Protein Levels Predict 6-Year Graft Survival after Endothelial Keratoplasty in Surgically Treated Glaucoma EyesSayaka Kaneko, Yukari Yagi-Yaguchi, Taiyo Shijo, et al.
Retina (Philadelphia, Pa.)|February 20, 2024
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata RegimenWataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pageof 3